Furthermore, the use of anti‐CSF1/CSF1R agents has demonstrated synergistic effects with ADT in managing PCa by reducing pro‐tumor CAM infiltration both in vitro and in vivo. The gene discussed is CSF1R; the disease is neoplasm.